Skip to content

Analysis of Risk Factors for Intrapartum Fever Associated with Epidural Analgesia for Labour

Analysis of Risk Factors for Fever During Labor Related to Epidural Analgesia: A Retrospective Cohort Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600126857
Enrollment
Unknown
Registered
2026-06-17
Start date
2026-06-25
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epidural labour analgesia-related fever

Interventions

Observation group:None

Sponsors

Tianjin Central Hospital of Gynecology Obstetrics
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1.Hospital delivery from 1 January 2024 to 31 December 2025, singleton, cephalic pregnancy; 2.Gestational age =37 weeks and =42 weeks (full-term delivery); 3.Voluntarily undergo epidural analgesia for labour, with successful implementation (block level reaches below T10, satisfactory analgesic effect, NRS pain score =3); 4.Complete clinical data (including general information, obstetric information, analgesia-related information, temperature monitoring data, maternal and neonatal outcome data, etc.); 5.No history of severe liver and kidney dysfunction, coagulation disorders, or infectious diseases;

Exclusion criteria

Exclusion criteria: 1.Those who experience failure of epidural labour analgesia or abandon analgesia midway; 2.Those who have a fever (temperature =38.0°C) or clear signs of infection (such as chorioamnionitis, upper respiratory tract infection, Group B streptococcus infection, etc.) before delivery (prior to epidural analgesia); 3.Those with multiple pregnancies, abnormal fetal positions (breech, transverse, etc.), preterm labour, or post-term pregnancies; 4.Those with severe pregnancy complications (such as severe preeclampsia, eclampsia, severe gestational diabetes, heart failure, etc.); 5.People allergic to epidural analgesics (such as ropivacaine, sufentanil, etc.); 6.Clinical data is severely lacking, making it impossible to complete data extraction and analysis;

Design outcomes

Primary

MeasureTime frame
Body temperature;

Secondary

MeasureTime frame
maternal and fetal outcome;severity of fever;

Countries

China

Contacts

Public ContactDong Hui

Tianjin Central Hospital of Gynecology Obstetrics

kessen_435@163.com+86 22 5828 7068

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 29, 2026